Details for Patent: 8,741,956

Which drugs does patent 8,741,956 protect, and when does it expire?

Patent 8,741,956 protects PENNSAID and is included in two NDAs.

Summary for Patent: 8,741,956

Patent landscape, scope, and claims:

Title:	Treatment of pain with topical diclofenac
Abstract:	The field involves compositions useful for pain relief, including diclofenac solution and gel formulations, in particular methods of use thereof, articles of manufacture and kits that provide novel preclinical, clinical and other information to users.
Inventor(s):	Singh; Jagat (Scarborough, CA), Shainhouse; Joseph Zev (North York, CA), Galer; Bradley S. (West Chester, PA), King-Smith; Robert Dominic (San Diego, CA), Grierson; Lisa Marie (Richmond Hill, CA), Burian; Maria (Stolberg, DE), Wilkin; Jonathan (Columbus, OH), Kisak; Edward (San Diego, CA), Newsam; John M. (La Jolla, CA)
Assignee:	Nuvo Research Inc. (Mississauga, CA)
Application Number:	13/668,061
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 8,741,956
Patent Claim Types: see list of patent claims	Use;

Drugs Protected by US Patent 8,741,956

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Horizon	PENNSAID	diclofenac sodium	SOLUTION;TOPICAL	204623-001	Jan 16, 2014		DISCN	Yes	No	8,741,956					COMBINATION USE OF TOPICAL DICLOFENAC ON THE KNEE AND ADMINISTRATION OF AN ORAL NSAID.
Nuvo Pharms Inc	PENNSAID	diclofenac sodium	SOLUTION;TOPICAL	020947-001	Nov 4, 2009		DISCN	Yes	No	8,741,956					COMBINATION USE OF TOPICAL DICLOFENAC ON THE KNEE AND ADMINISTRATION OF AN ORAL NSAID.